Share
3,171 Posts.
lightbulb Created with Sketch. 434
clock Created with Sketch. 02/02/18
16:00
Share
Originally posted by underdone
↑
The wording in the report accompanying the 4C was as follows:40 products required to be developed under the existing licensing agreement for the second technology have been delivered for initial consumer efficacy testing. This fulfils the first important phase of the program and enables consumer feedback to define the next stage, including the development of final products and software.a broader range of distribution pathways to be deployed. the development and distribution of products containing the second technology. enabling OBJ to offer products to the market containing microarray technology in these sectors. products containing the second technology", and "enabling OBJ to offer products to the market containing microarray technology in these sectors.", and "a broader range of distribution pathways to be deployed." all seem to imply distinctly separate applications of the company's technology.40 products required to be developed " as merely 40 samples of the one product line.
Expand
Thank you ....FOR YOUR EFFORT ...much appreciated...and I do believe this could well be a major turning point for the company, but it will take time for the revenues to flow. So let's hope that when and if signed that the potential of this second technology becomes tangibly obvious
(20min delay)